The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
Appili receives FDA approval to test drug that could prevent COVID-19 spread at long-term care facilities (BETAKIT)
The drug, called favipiravir, is an antiviral that can be administered orally as a tablet.
With COVID-19, it has never been more important to understand how Canadian firms innovate. The Conference Board of Canada is publishing an in-depth study on how innovation translates into growth.
Canadian tech firms and ecosystem partners are invited to join the survey. You will be first to receive the full report.
The Oura Ring has been getting a lot of attention lately because of its role in a number of COVID-19 studies, as well as its adoption by both the NBA and WNBA as a potential tool for helping prevent any outbreaks of the novel coronavirus as those two leagues get back to a regular schedule of play.
Inside a year of rapid growth – and undeniable risk – for a Canadian mask manufacturer (THE GLOBE AND MAIL)
Medicom undertook a global expansion in just eight months, overcoming protectionist policies and government intervention. It plans to keep going, even after that pandemic fades.
Sprout, which offers a digital wellbeing solution for workplaces, has acquired Calgary-based predictive health data analytics company Vivametrica.
England has started testing a contact tracing app — again (MIT TECHNOLOGY REVIEW)
A new COVID-19 app is being rolled out by England’s NHS after technical issues killed its first attempt.
What role will compliance play in interoperability? (HEALTHTECH MAGAZINE)
New federal interoperability rules aim to make it easier for consumers to access their own health data, but they will also require organizations to adopt new technologies and data-sharing standards to meet the requirements.
The hazards of digital mental health (MOBIHEALTHNEWS)
Why are so few digital mental health tools based in evidence? The answer is complicated.
Atomwise raises $163 million Series B (BETAKIT)
Atomwise, which operates an AI-based drug discovery platform, has raised $163 million CAD in what it called an oversubscribed Series B financing round.
Direct-to-consumer health company Thirty Madison raises $47M (MED CITY NEWS)
Thirty Madison, which operates three brands for hair loss, migraines and acid reflux, raised $47 million in a series B round.
Copenhagen-based healthtech Practio lands €8.2 million to speed up its international expansion (EU STARTUPS)
Initial Practio services include vaccinations and COVID-19 antibody testing, but the company is planning to roll out broader platform services over time.